Circulating Tumor Biomarkers: New Paradigms for Management of Neuroblastoma |
University of Chicago / Mark Applebaum, PhD |
'A' Award Grants |
2021 |
Illinois |
Circumventing Pediatric Solid Tumor Microenvironment Resistance by Combinatorial CAR NK and Immunomodulating Therapy |
New York Medical College / Mitchell Cairo, MD |
Reach Grants |
2023 |
New York |
Clinical Development of RNA Nanoparticle Vaccines Targeting Recurrent Pediatric Brain Cancers |
Duke University / Duane Mitchell, MD, PhD |
Innovation Grants |
2011 |
North Carolina |
Clinical Epidemiology Studies in Children's Oncology Group Clinical Trials |
Children’s Hospital of Philadelphia / Richard Aplenc, MD, PhD, MSCE |
Epidemiology Grants |
2013 |
Pennsylvania |
CLL-1 CAR-T cells with or without trametinib for the treatment of JMML |
The Regents of the University of California San Francisco / Elliot Stieglitz, MD |
R Accelerated Award Grants |
2023 |
California |
Columbia University Developmental Therapeutics Program: Striving for Excellence
|
Columbia University / Julia Glade Bender, MD |
Phase I/II Infrastructure Grants |
2013 |
New York |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database |
Huntsman Cancer Institute / Joshua Schiffman, MD |
Epidemiology Grants |
2010 |
Utah |
Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database |
Huntsman Cancer Institute / Joshua Schiffman, MD |
Epidemiology Grants |
2012 |
Utah |
Converting the Glioblastoma Multiforme Tumor-Associated Macrophage Phenotype |
The Johns Hopkins University School of Medicine / Alan D. Friedman, M.D. |
Innovation Grants |
2014 |
Maryland |